Sign in

CIK 0001720893

  • Non-accelerated filer
  • Smaller reporting company

BioXcel Therapeutics, Inc.

Sign in to watch
Ticker
BTAIQ
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
821386754
Phone
+1 203-643-8060
Business address
555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
  1. 4 Planned sale O'Neill Vincent sold 155 shares at $1.29 ($199)
  2. 4 Planned sale CEO and President sold 2,134 shares at $1.28 ($2,739)
  3. 4/A Insider Changes in Ownership
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market sale CEO and President sold 1,427,494 shares at an average $1.61 ($405,135)
  10. 4 Planned sale O'Neill Vincent sold 165 shares at $2.62 ($432)
  11. 4 Planned sale CEO and President sold 5,268 shares at an average $2.62 ($13,823)
  12. 4 Planned sale Chief Financial Officer sold 1,069 shares at $2.64 ($2,817)
  13. 4 Planned sale CHIEF COMMERCIAL OFFICER sold 1,008 shares at $2.64 ($2,656)
  14. 4 Planned sale Rodriguez Javier sold 1,012 shares at $2.64 ($2,667)
  15. 4 Planned sale Chief Scientific Officer sold 1,067 shares at $2.64 ($2,812)
  16. 4 Exercise or conversion Chief Scientific Officer acquired 521 shares (option exercise)
  17. 4 Exercise or conversion CEO and President acquired 2,609 shares (option exercise)
  18. 4 Exercise or conversion Rodriguez Javier acquired 521 shares (option exercise)
  19. 4 Exercise or conversion Chief Financial Officer acquired 521 shares (option exercise)
  20. 4 Exercise or conversion Chief Medical Officer acquired 521 shares (option exercise)

Page 6 of 14 · 276 filings